Laboratories That Test for GNAQ Mutations
Advances in our understanding of the molecular mechanisms driving melanoma have uncovered mutations (e.g. GNAQ) whose effects could be reduced by targeted therapies (e.g. MEK inhibitors). Testing individual tumors for such mutations may help select relevant therapies. The following laboratories offer testing for GNAQ mutations that could identify patients likely to benefit from treatment with MEK inhibitors.
| Vendor | Vendor Test/Assay Unique Identifier | Contact Information |
|---|---|---|
| Memorial Sloan-Kettering Cancer Center - Pathology Consulting Services | (212) 639-5905 |
Our goal is to provide a comprehensive list of laboratories that conduct GNAQ mutational analysis.
If your company conducts this test but is not listed, Email Us.